Timothée Chalamet Draws Backlash From Ballet and Opera
A single public remark can ripple through the arts ecosystem and even into personal finances. This article explains h...
Timing matters: automatic rebalancing should occur as your allocations drift beyond set thresholds.
18,157 articlesA single public remark can ripple through the arts ecosystem and even into personal finances. This article explains h...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A large Bitcoin transfer to Gemini has reignited questions about whether the Winklevoss twins are selling BTC. Arkham...
Investors chase the next big AI champion. This piece breaks down how a single AI stock could grow into a trillion-dol...
NVIDIA is expanding beyond chips into cloud AI infrastructure. This move signals a broader AI ecosystem pivot that co...
Palantir stock has faced volatility, but March is showing momentum. This deep dive explores why March could turning p...
Biotech stocks rally as late-stage trial data and regulatory milestones boost investor confidence. Analysts say the b...
A major adviser boosted its stake in Savara by more than a million shares during the latest quarter, wading into a bi...
As the AI boom accelerates, the inference layer becomes the engine. This article explains why artificial intelligence...
As Abeona prepares to report 2025 results, investors need a clear framework to interpret the numbers. This guide brea...
As brokerages race to attract new investors, free stock promotions are surging in March 2026. This report explains ho...
European stocks slump as Middle East tensions lift rate expectations for the ECB and BoE, signaling a new Atlantic ri...